Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




New Test Provides Accurate PCR results for Four Most Common Respiratory Viruses

By LabMedica International staff writers
Posted on 06 Aug 2025

Respiratory illnesses such as SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV) often present with overlapping symptoms, making accurate and timely diagnosis difficult. More...

Delays in diagnosis can hamper the prompt initiation of appropriate treatment, contributing to repeated healthcare visits and inefficient testing workflows. Laboratories have long struggled with rigid test panels that fail to align with evolving respiratory demands or specific clinical needs. Now, an innovative syndromic PCR testing solution can simultaneously detect and differentiate these four most common respiratory viruses, helping to ensure confidence in diagnosis.

Roche Diagnostics’ (Basel, Switzerland) new cobas Respiratory 4-flex offers qualitative PCR-based detection and differentiation of SARS-CoV-2, influenza A and B, and RSV from nasopharyngeal swab specimens. The test uses the company’s proprietary TAGS (Temperature-Activated Generation of Signal) technology which enables multiplex PCR testing with the ability to detect multiple viral targets within a single optical channel using a combination of color, temperature, and advanced data processing. A notable feature is the "digital reflex" option, which allows clinicians to obtain additional results from the same test run if initial target results are negative—streamlining patient care and reducing the need for re-testing. Laboratories can also customize the test panel based on physician orders and clinical requirements, allowing for flexible, targeted diagnostics.

By combining TAGS technology with high-throughput capabilities and customizable panels, the test supports diagnostic stewardship and broader patient access. The cobas Respiratory 4-flex test is compatible with Roche’s cobas 5800, 6800, and 8800 systems and has been granted FDA 510(k) clearance, making it well-positioned to improve respiratory diagnostics across healthcare settings. Roche plans to build on this innovation by expanding its respiratory portfolio to address future needs for viral and bacterial testing, leveraging the groundwork laid by this platform to develop further multiplex diagnostic solutions.

"The cobas Respiratory 4-flex assay offers a significant technological advancement that empowers labs to address evolving respiratory testing demands now and, in the future," said Brad Moore, President and CEO of Roche Diagnostics North America. "The expanded testing capabilities, enabled by TAGS technology, will allow labs to deliver reliable and relevant patient testing, while also optimizing healthcare resources."

"Our goal for the Respiratory 4-flex is to allow labs to customize testing based on clinical needs, patient symptoms, which are often similar, and to better support a constantly shifting respiratory landscape," added Denise Heaney, Ph.D., Chief Medical Partner, Molecular Solutions and Infectious Disease at Roche Diagnostics. "TAGS technology allows for the detection of more targets on a high-throughput platform, which supports diagnostic stewardship while reaching a broader patient population."


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: An innovative deep learning model can accurately predict MSI tumor and immune checkpoint inhibitor responsiveness (Photo courtesy of Jae-Ho Cheong/Yonsei University College of Medicine)

AI Model Accurately Predicts MSI Tumor and Immune Checkpoint Inhibitor Responsiveness

One in three people is expected to develop cancer in their lifetime, and a key factor in patient prognosis is the tumor’s microsatellite status—whether it is stable or shows microsatellite instability-high (MSI-H).... Read more

Pathology

view channel
Image: Virtual staining of label-free tissue in imaging mass spectrometry (Photo courtesy of Ozcan Lab/UCLA)

Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. However, IMS is hindered by relatively low... Read more

Industry

view channel
Image: Alzheimer’s Association has released its first clinical practice guideline for blood-based biomarker tests (Photo courtesy of Alzheimer’s Association)

New Clinical Guidelines Recommend Use of Blood Tests Instead of Brain Scans for Alzheimer’s Diagnosis

Alzheimer’s disease is a progressive neurodegenerative condition that remains challenging to diagnose early and accurately, particularly in individuals with cognitive impairment. Despite the availability... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.